Simple Death JAB Expansion.
Novavax Developing Vaccine Against Variant That Appeared 72 Hours Ago – Will Be Ready in Two Weeks, Already in Emergency Use Trials in Indonesia and Phillipines
November 26, 2021 | Sundance | 53 Comments
Wow, 72 hours ago no one even heard the name Omicron variant. Now, in less than three days, a variant has been identified, global travel has been halted, states of emergency have been declared, and now we see a pharmaceutical company announcing the variant specific vaccine trial that will begin in the U.S. in a few weeks. This government relationship with Big Pharma is certainly generating some fast action, eh?
If a person was cynically inclined; while knowing governments’ need to control inflation yet cannot raise interest rates or stop purchasing debt because current legislative spending continues – a remarkable control option would be to halt demand; and a person might think this was suspicious, or something.
http://theconservativetreehouse.com/
At least it isn’t the same shot from the version of COVID-19 from two years ago, in China.
All the boosters have been the old shot, all over again.
Let's motivate Mother Nature to create even MORE deadly variants of the spike protein!
Funny. The medical community just had to skip “Xi” in the Greek alphabet and jump from Nu to Omicron.
Seems like it was planned. Of course there will be fools pushing in line wanting the newest vaxx
Wasn’t it just discovered leas than a week ago?
The long shot [Novavax Covid Vaccine]
sciencemag.org ^ | 06 Nov 2020: | Meredith Wadman
Posted on 6/15/2021, 11:38:33 PM by ransomnote
Novavax's vaccine is made of tiny particles studded with the coronavirus spike protein plus honeycomblike molecules, derived from plants, that stimulate the immune system.
Image of Novavax's tiny particles studded with coronavirus spike proteins
Eighteen months ago, a small vaccinemaker here called Novavax faced an existential threat: delisting by the NASDAQ stock index. On the heels of a second failed vaccine trial in less than 3 years, the firm's shares had plunged to less than $1 for 30 straight days, triggering a warning by NASDAQ. Frantic to conserve cash, the company sold its two Maryland manufacturing facilities, slicing its payroll by more than 100 employees. By January, it employed only 166 people.
“Good ideas. Bad management. … The company will probably die soon,” a former Novavax manager wrote on Glassdoor.com in October 2019.
Leaky vaccines lead to Marek’s Disease in chickens.
https://en.wikipedia.org/wiki/Marek‘s_disease
We are playing with fire here!
Sure they are.
Yeah, go team! Does this count at the first or second booster in covid vaccine bingo? :-/
I predicted a 2nd booster by May or June of 2022.
Guess that will be a little late.
After all, a new booster will be needed for the 27-plus variants that will come...
Oh, brother. I thought this was satire.
Yet another genetic experiment with humans as the lab rats.
STOP THE MADNESS!
Get a load of Gov Hochul’s response in NYS...
https://www.governor.ny.gov/executive-order/no-11-declaring-disaster-emergency-state-new-york
Especially this bit...
“IN ADDITION, this declaration satisfies the requirements of Part 360 of the New York State Codes, Rules and Regulations to allow the state to utilize the Surge and Flex system, which may include, but is not limited to, postponement of non-essential elective procedures.”
As you speak.....
omicron/moronic
